Our significant observation that inhibition of FAM83B expression can suppress the activity of both CRAF and PI3K signaling provides an exciting new target for future therapies aimed at inhibiting both pathways simultaneously to inhibit tumor growth. Here, RAF1 is linked to neoplasm.